In contrast to sporadic colorectal carcinomas, in which the majority harbors APC, CTNNB1 or KRAS mutations, colorectal carcinomas that arise in the setting of chronic inflammatory diseases have a very low frequency of these mutations [43, 44]. This evidence concerns the gene CTNNB1 and colorectal carcinoma.